Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma
Journal for ImmunoTherapy of Cancer · 2026-01 · 14 (1) · e014067
DOI: 10.1136/jitc-2025-014067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 30.01.2026. Verfasst von Maxwell Y Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Cutaneous Squamous Cell Carcinoma, Skin Neoplasms, Programmed Cell Death 1 Receptor, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCR NIH HHS, Regeneron, Genentech.
Abstract (Originalsprache)
Background
Neoadjuvant PD-1/PD-L1 blockade yields robust efficacy in advanced cutaneous squamous cell carcinoma (cSCC), yet many patients fail to achieve a complete or major pathologic response. The reasons why some patients experience response but others do not are unclear.
Methods
We profiled cSCC specimens before, after 1 dose, and after 3–4 doses of PD-1/PD-L1 blockade to uncover resistance mechanisms and predict therapeutic response. In total, 27 patients across three cohorts, including two phase II trials, were studied. We created 1.7 mm tissue-core microarrays and performed single-cell spatial transcriptomics, including spatial clustering, gene-set enrichment, and spatial correlation analyses.
Results
After profiling all samples, six distinct spatial niches emerged, each differentially enriched in responders versus non-responders. A high antigen presentation niche, B/plasma cell enriched niche, and inflammatory keratinocyte niche were more frequent in responders, whereas proliferative keratinocyte, low antigen presentation myeloid, and fibroblast-rich epithelial–mesenchymal transition niches prevailed in non-responders. Notably, spatial niche profiling on pretreatment samples outperformed PD-L1 status in predicting pathologic response. Each niche displayed unique gene coexpression modules, suggesting niche-specific resistance mechanisms. Individual tumor analyses revealed varied immune evasion strategies, including defective interferon-induced antigen presentation, immunosuppressive myeloid environments, and epithelial–mesenchymal transition.
Conclusions
Our single-cell spatial transcriptomic approach identifies six spatial niches that predict immunotherapy response better than PD-L1 status using only 1.7 mm tissue cores and may inform the development of biomarkers. Our results further underscore the heterogeneity of resistance mechanisms among cSCC patients, highlighting the need for tailored therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA.
- Stanford Cancer Institute Clinical Trials Office, Stanford University School of Medicine, Palo Alto, California, USA.
- Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
- Department of Medicine, Division of Medical Oncology, Stanford University, Palo Alto, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA vdivi@stanford.edu sunwoo@stanford.edu.
Förderung
- NIDCR NIH HHS
- Regeneron
- Genentech
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Lee, M. Y., Sherman, A. R., Martinez Ramirez, L., Rahman, M., Zdravkovic, S., Shin, J. H., Stepanek, I., Colevas, A. D., Sunwoo, J. B., & Divi, V. (2026). Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. Journal for ImmunoTherapy of Cancer, 14(1), e014067. https://doi.org/10.1136/jitc-2025-014067
Vancouver
Lee MY, Sherman AR, Martinez Ramirez L, Rahman M, Zdravkovic S, Shin JH, et al. Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 2026;14(1):e014067. doi:10.1136/jitc-2025-014067
BibTeX
@article{Lee2026,
author = {Lee, Maxwell Y and Sherman, Alistaire R and Martinez Ramirez, Luis and Rahman, Mobeen and Zdravkovic, Sabrina and Shin, June Ho and Stepanek, Ivan and Colevas, Alexander Dimitrios and Sunwoo, John B and Divi, Vasu},
title = {Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {1},
pages = {e014067},
doi = {10.1136/jitc-2025-014067}
}
EUVIMED